Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2025-12-26 @ 2:34 AM
NCT ID: NCT02332902
Description: None
Frequency Threshold: 0
Time Frame: 6 months
Study: NCT02332902
Study Brief: Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Intervention This is a single arm intervention using Everolimus. Everyone in the study will receive Everolimus at a starting dose of 10 mg daily and will be adjusted up or down by 2.5 mg at 2-week intervals to attain a trough concentration of 5-15 ng/mL. 0 None 0 22 22 22 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Stomatitis NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Upper Respiratory Infection/Cough/Sinus Infection/Pneumonia/Pharyngitis NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Gastrointestinal (GI) Upset NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Folliculitis/Impetigo/Rash/Itching NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Decreased Per Oral Intake/Weight loss NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Headache NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Tooth Infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations None View
Urinary Tract Infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations None View
Fatigue NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Erythema Nodosum NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Vaginitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations None View
Thrush NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Pneumonitis NON_SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders None View
Bladder Leakage NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders None View
Pheochromocytoma NON_SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) None View
Ingrown Toenail NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Nose Bleed NON_SYSTEMATIC_ASSESSMENT Vascular disorders None View
Hypercholesterolemia NON_SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders None View
Left Side Numbness NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Biopsy Infection NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Foggy Hearing NON_SYSTEMATIC_ASSESSMENT Ear and labyrinth disorders None View
Ammenorrhea NON_SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders None View
Ovarian Cyst NON_SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders None View